{"url_path":"/sec/elv/8-k/2026-05-13/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1156039/0001156039-26-000046-index.html","accession_number":"0001156039-26-000046","cik":"0001156039","ticker":"ELV","issuer_name":"Elevance Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1156039/0001156039-26-000046-index.html","primary_entity_key":"0001156039","primary_entity_name":"Elevance Health, Inc."},"word_count":311,"has_tables":true,"body_markdown":"Item 5.07 - Submission of Matters to a Vote of Security Holders\n\nOn May 13, 2026, Elevance Health, Inc. (the \"Company\") held its Annual Meeting of Shareholders (the \"Annual Meeting\"). There were 194,441,339 shares of common stock represented at the Annual Meeting, constituting a quorum. The shareholders of the Company voted as follows on the matters set forth below:\n\n1.Election of Directors. The following nominees for director were elected to serve three-year terms to expire at the Company’s annual meeting of shareholders in 2029 based on the following votes:\n\nNominee\n\nFor\n\nAgainst\n\nAbstain\n\nBroker Non-Votes\n\nGail K. Boudreaux\n\n177,978,713\n\n1,714,229\n\n110,827\n\n14,637,570\n\nRobert L. Dixon, Jr.\n\n174,098,489\n\n5,590,793\n\n114,487\n\n14,637,570\n\nDeanna D. Strable\n\n175,331,822\n\n4,360,980\n\n110,967\n\n14,637,570\n\n2.Advisory vote on the Company’s executive compensation. The advisory vote on the compensation of the Company’s named executive officers was approved based upon the following votes:\n\nFor\n\nAgainst\n\nAbstain\n\nBroker Non-Votes\n\n172,363,616\n\n7,240,619\n\n199,534\n\n14,637,570\n\n3.Ratification of the appointment of Ernst & Young LLP. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified based upon the following votes:\n\nFor\n\nAgainst\n\nAbstain\n\n175,183,332\n\n19,141,697\n\n116,310\n\n4.Shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups. The shareholder proposal requesting a study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups was not approved based upon the following votes:\n\nFor\n\nAgainst\n\nAbstain\n\nBroker Non-Votes\n\n15,587,160\n\n162,924,290\n\n1,292,319\n\n14,637,570\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 13th day of May, 2026.\n\nELEVANCE HEALTH, INC.\n\nBy:\n\n/s/ Kathleen S. Kiefer\n\nName:\n\nKathleen S. Kiefer\n\nTitle:\n\nChief Governance Officer and Corporate Secretary"}